학술논문

Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential
Document Type
article
Source
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Rare Diseases
Digestive Diseases
Cancer
2.1 Biological and endogenous factors
Aetiology
Adult
Aged
Aged
80 and over
Biomarkers
Tumor
Cell Proliferation
Class I Phosphatidylinositol 3-Kinases
DNA Mutational Analysis
Diagnosis
Differential
Female
GTP-Binding Protein alpha Subunits
Gq-G11
Hemangioma
Cavernous
Hemangiosarcoma
Humans
Immunohistochemistry
Ki-67 Antigen
Liver Neoplasms
Male
Middle Aged
Mutation
Neoplasm Grading
Phosphatidylinositol 3-Kinases
Predictive Value of Tests
Proto-Oncogene Proteins c-myc
Terminology as Topic
Tumor Suppressor Protein p53
Vascular Neoplasms
Young Adult
Liver
Hemangioma
Angiosarcoma
Hepatic small vessel neoplasm
GNAQ
Clinical Sciences
Pathology
Clinical sciences
Language
Abstract
Characteristic but rare vascular neoplasms in the adult liver composed of small vessels with an infiltrative border were collected from an international group of collaborators over a 5-year period (N=17). These tumors were termed hepatic small vessel neoplasm (HSVN), and the histologic differential diagnosis was angiosarcoma (AS). The average age of patients was 54years (range, 24-83years). HSVN was more common in men. The average size was 2.1cm (range, 0.2-5.5cm). Diagnosis was aided by immunohistochemical stains for vascular lineage (CD31, CD34, FLI-1), which were uniformly positive in HSVN. Immunohistochemical stains (p53, c-Myc, GLUT-1, and Ki-67) for possible malignant potential are suggestive of a benign/low-grade tumor. Capture-based next-generation sequencing (using an assay that targets the coding regions of more than 500 cancer genes) identified an activating hotspot GNAQ mutation in 2 of 3 (67%) tested samples, and one of these cases also had a hotspot mutation in PIK3CA. When compared with hepatic AS (n=10) and cavernous hemangioma (n=6), the Ki-67 proliferative index is the most helpful tool in excluding AS, which demonstrated a tumor cell proliferative index greater than 10% in all cases. Strong p53 and diffuse c-Myc staining was also significantly associated with AS but not with HSVN or cavernous hemangioma. There have been no cases with rupture/hemorrhage, disseminated intravascular coagulation, or Kasabach-Merritt syndrome. Thus far, there has been no metastasis or recurrence of HSVN, but complete resection and close clinical follow-up are recommended because the outcome remains unknown.